KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $15.0 billion.

  • Pfizer's Cash & Current Investments rose 5056.27% to $15.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 billion, marking a year-over-year increase of 5056.27%. This contributed to the annual value of $20.5 billion for FY2024, which is 6136.33% up from last year.
  • Pfizer's Cash & Current Investments amounted to $15.0 billion in Q3 2025, which was up 5056.27% from $13.2 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Cash & Current Investments registered a high of $44.8 billion during Q3 2023, and its lowest value of $7.1 billion during Q2 2024.
  • Moreover, its 5-year median value for Cash & Current Investments was $20.5 billion (2024), whereas its average is $22.6 billion.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 15418.47% in 2021, then plummeted by 8414.65% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Cash & Current Investments stood at $31.1 billion in 2021, then dropped by 26.83% to $22.7 billion in 2022, then tumbled by 44.18% to $12.7 billion in 2023, then surged by 61.36% to $20.5 billion in 2024, then fell by 26.83% to $15.0 billion in 2025.
  • Its Cash & Current Investments was $15.0 billion in Q3 2025, compared to $13.2 billion in Q2 2025 and $17.3 billion in Q1 2025.